🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

W. Clay Gustafson

Revolution Medicines (United States)

ORCID: 0000-0002-1812-5675

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53”.

The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53

Neoplasia(2021)10.1016/j.neo.2021.05.003

N/A

0DataRank · unranked

15 citations

Oscar Sias‐Garcia, Nicole Nasholm, Xiaoyu Hu, Amanda Balboni Iniguez, Matthew D. Hall +12 more

GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma

JCI Insight(2022)10.1172/jci.insight.162207

N/A

0DataRank · unranked

7 citations

David V. Allegakoen, José A. Garcı́a, Kristen Kwong, Pushpendra K. Sahu, Drew A. Fajardo +7 more

ALK upregulates POSTN and WNT signaling to drive neuroblastoma

Cell Reports(2024)10.1016/j.celrep.2024.113927

N/A

0DataRank · unranked

16 citations

Wanqi Fang, Alvin Farrel, Linwei Li, Antonios Chronopoulos, Nicole Nasholm +17 more

Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma

The Journal of Experimental Medicine(2025)10.1084/jem.20231417

N/A

0DataRank · unranked

3 citations

Hiroyuki Yoda, Nicole Nasholm, Megumi J. Barata, Linyu Wang, Erin F. Simonds +15 more